| Literature DB >> 30123202 |
Hironaga Akita1, Junji Hayashi2, Haruhiko Sakuraba3, Toshihisa Ohshima4.
Abstract
Many kinds of NAD(P)+-dependent L-amino acid dehydrogenases have been so far found and effectively used for synthesis of L-amino acids and their analogs, and for their sensing. By contrast, similar biotechnological use of D-amino acid dehydrogenase (D-AADH) has not been achieved because useful D-AADH has not been found from natural resources. Recently, using protein engineering methods, an NADP+-dependent D-AADH was created from meso-diaminopimelate dehydrogenase (meso-DAPDH). The artificially created D-AADH catalyzed the reversible NADP+-dependent oxidative deamination of D-amino acids to 2-oxo acids. The enzyme, especially thermostable one from thermophiles, was efficiently applicable to synthesis of D-branched-chain amino acids (D-BCAAs), with high yields and optical purity, and was useful for the practical synthesis of 13C- and/or 15N-labeled D-BCAAs. The enzyme also made it possible to assay D-isoleucine selectively in a mixture of isoleucine isomers. Analyses of the three-dimensional structures of meso-DAPDH and D-AADH, and designed mutations based on the information obtained made it possible to markedly enhance enzyme activity and to create D-AADH homologs with desired reactivity profiles. The methods described here may be an effective approach to artificial creation of biotechnologically useful enzymes.Entities:
Keywords: D-amino acid; Ureibacillus thermosphaericus; crystal structure analysis; meso-diaminopimelate dehydrogenase; protein engineering; stable isotope-labeled D-amino acid; thermostable D-amino acid dehydrogenase
Year: 2018 PMID: 30123202 PMCID: PMC6085447 DOI: 10.3389/fmicb.2018.01760
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Substrate specificities of D-AADH and its mutants.
| Substrate | Oxidative deamination | |||
|---|---|---|---|---|
| His-tagged | Non-tagged | Asp94Ala Specific activity (μmol/min/mg) | Tyr224Phe Specific activity (μmol/min/mg) | |
| 0.00738 ± 0.0002 | 0.722 ± 0.024 | 0.0815 ± 0.0027 | 0.337 ± 0.012 | |
| - | 0.0168 ± 0.0003 | 0.139 ± 0.003 | 0.0139 ± 0.0001 | |
| 0.193 ± 0.003 | 0.113 ± 0.002 | 1.70 ± 0.05 | 0.0763 ± 0.0016 | |
| 0.106 ± 0.004 | 0.191 ± 0.002 | 4.80 ± 0.11 | 0.0895 ± 0.0015 | |
| 0.299 ± 0.001 | 10.8 ± 0.1 | 1.32 ± 0.06 | 2.25 ± 0.02 | |
| 0.0178 ± 0.0009 | 0.213 ± 0.006 | 2.60 ± 0.11 | 0.173 ± 0.004 | |
| 0.107 ± 0.002 | 0.419 ± 0.020 | 4.22 ± 0.10 | 0.315 ± 0.008 | |
| 0.0106 ± 0.0002 | 0.099 ± 0.002 | 5.33 ± 0.14 | 0.0769 ± 0.0005 | |
| - | 0.0369 ± 0.0020 | 0.244 ± 0.006 | 0.0186 ± 0.0002 | |
| 0.0142 ± 0.0008 | 0.121 ± 0.004 | 0.185 ± 0.005 | 0.0711 ± 0.0017 | |
| 2-Oxooctanoate | 2.27 ± 0.06 | 13.2 ± 0.1 | 65.5 ± 0.8 | 11.7 ± 0.5 |
| Phenylpyruvate | 0.235 ± 0.005 | 1.93 ± 0.02 | 16.1 ± 0.3 | 1.67 ± 0.02 |
| Pyruvate | 0.0688 ± 0.0020 | 0.470 ± 0.029 | 0.131 ± 0.004 | 0.138 ± 0.003 |
| 2-Oxobutanoate | 0.201 ± 0.002 | 2.47 ± 0.03 | 0.859 ± 0.052 | 0.85 ± 0.01 |
| 2-Oxohexanoate | 1.03 ± 0.06 | 9.21 ± 0.13 | 35.0 ± 0.9 | 7.56 ± 0.17 |
| 2-Oxopentanoate | 0.465 ± 0.015 | 4.72 ± 0.08 | 7.63 ± 0.20 | 3.44 ± 0.10 |
| 2-Oxo-3-methylbutanoate | 0.279 ± 0.004 | 2.54 ± 0.05 | 1.04 ± 0.03 | 1.89 ± 0.01 |
| 2-Oxo-3-methylpentanoate | 0.310 ± 0.007 | 2.23 ± 0.05 | 3.90 ± 0.06 | 2.25 ± 0.07 |
| 2-Oxo-4-methylpentanoate | 0.624 ± 0.012 | 4.78 ± 0.11 | 15.7 ± 0.2 | 4.64 ± 0.06 |
| 2-Oxo-4-methylthio butanoate | 0.624 ± 0.012 | 6.37 ± 0.09 | 25.0 ± 0.8 | 6.22 ± 0.12 |
Production of stable isotope-labeled D-BCAAs.
| Product | Substrate | Optical purity (%)a | Chemical shift (ppm) | Yield (%) | |
|---|---|---|---|---|---|
| [1-13C]2-Oxo-4-methylpentanoate, [15N]NH4Cl | >99% | 134.10 | 176.03 [13C] 47.32 [15N] | 99 ± 1 | |
| [1-13C]2-Oxo-4-methylpentanoate, NH4Cl | >99% | 133.10 | 176.03 | 99 ± 1 | |
| 2-Oxo-3-methylpentanoate, [15N]NH4Cl | >99% | 133.10 | 39.90 | 49 ± 1 | |
| 2-Oxo-4-methylpentanoate, [15N]NH4Cl | >99% | 133.10 | 47.32 | 99 ± 0 | |
| 2-Oxo-3-methylbutanoate, [15N]NH4Cl | >99% | 119.08 | 43.09 | 99 ± 1 | |